An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. (2016)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddw223
PubMed Identifier: 27402876
Publication URI: http://europepmc.org/abstract/MED/27402876
Type: Journal Article/Review
Volume: 25
Parent Publication: Human molecular genetics
Issue: 17
ISSN: 0964-6906